Compare Nebius Group NV (NBIS) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nebius Group NV vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Nebius Group NV trades at $177.73 (market cap $50.57B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Nebius Group NV is far larger — about 4.8× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Nebius Group NV pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nebius Group NV for 25 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| NBIS | RDY | |
|---|---|---|
Market Cap | $50.57B | $10.61B |
Volume | 33,609,105 | 3,738,869 |
Sector | Technology | Health |
52-Week High | $286.69 | $15.38 |
52-Week Low | $73.87 | $11.38 |
Typical Hold Time | 25 Days | 0 Days |
Enterprise Value | $52.70B | $10.51B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NBIS trades at $206.86, down 1.52% today, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth potential with a $37 billion backlog and major AI infrastructure deals, though profitability remains challenged with a 3.13% net margin. Analyst consensus is strongly bullish with a $288.67 price target, representing 39% upside potential from current levels.
The stock presents high-risk, high-reward potential with significant AI infrastructure expansion driving growth, but faces execution risks from massive capital expenditures and competitive pressures. Current valuation metrics appear stretched with P/E of 715 and P/S of 38, requiring flawless execution to justify premium pricing amid concerns about AI market sustainability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
